Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Reduction of First Heart Attack, Stroke in Patients With Use of Recently Approved Drug

php logoDeepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of Medicine at Harvard Medical School, discusses the benefits of Brilinta for reducing a first heart attack or stroke in patients with coronary artery disease. 

 

Advertisement

Advertisement

Advertisement